Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Hemochromatosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03990181
What this trial is testing

Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement

Who this might be right for
Iron Metabolism DisordersIron OverloadPolyphenols
Swiss Federal Institute of Technology 14
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Testing effectiveness (Phase 2)Study completedNCT00349453
What this trial is testing

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Who this might be right for
Hemochromatosis
Lipomed 24
Large-scale testing (Phase 3)Study completedNCT00202436
What this trial is testing

Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

Who this might be right for
Hemochromatosis
Sanquin Research & Blood Bank Divisions 40
Not applicableUnknownNCT01524757
What this trial is testing

Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis

Who this might be right for
Hemochromatosis
Maastricht University Medical Center 48
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Not applicableStudy completedNCT00001203
What this trial is testing

Deferoxamine for the Treatment of Hemochromatosis

Who this might be right for
Diabetes MellitusHeart DiseaseHemochromatosis+1 more
National Heart, Lung, and Blood Institute (NHLBI) 151
Not applicableStudy completedNCT03453918
What this trial is testing

Effects of Polyphenols on Iron Absorption in Iron Overload Disorders.

Who this might be right for
Dysmetabolic Iron Overload SyndromeGenetic HemochromatosisIron Absorption+1 more
University Hospital, Clermont-Ferrand 41
Testing effectiveness (Phase 2)Study completedNCT00067080
What this trial is testing

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Anemia, Sickle Cell
Novartis Pharmaceuticals 195
Testing effectiveness (Phase 2)Looking for participantsNCT07332091
What this trial is testing

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

Who this might be right for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring 84
Not applicableStudy completedNCT06336577
What this trial is testing

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Who this might be right for
Down Syndrome
Centre Hospitalier Sud Francilien 108
Not applicableStudy completedNCT03356548
What this trial is testing

Transferrin Saturation and Asthenia in Hemochromatosis

Who this might be right for
Hemochromatoses, Genetic
Rennes University Hospital 260
Not applicableStudy completedNCT01810965
What this trial is testing

Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis

Who this might be right for
Hemochromatosis Type 1
Rennes University Hospital 6
Not applicableStudy completedNCT00005559
What this trial is testing

Statistical Basis for Hemochromatosis Screening

Who this might be right for
Blood DiseaseHemochromatosis
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT00712738
What this trial is testing

Oral Nifedipine to Treat Iron Overload

Who this might be right for
ThalassemiaIron OverloadHemochromatosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 6
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Testing effectiveness (Phase 2)Looking for participantsNCT07371793
What this trial is testing

Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
Bond Biosciences 34
Not applicableStudy completedNCT02099214
What this trial is testing

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

Who this might be right for
Myocardial Iron OverloadHFE-Associated Hereditary Hemochromatosis
Rennes University Hospital 66
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Next Page